Presentation is loading. Please wait.

Presentation is loading. Please wait.

David D. Berg et al. JACC 2018;71:

Similar presentations


Presentation on theme: "David D. Berg et al. JACC 2018;71:"— Presentation transcript:

1 David D. Berg et al. JACC 2018;71:1483-1493
Unique Aspects of CIED Programming in LVAS-Supported Patients There are limited data to guide decision-making pathways for cardiac implantable electronic devices (CIEDs) in left ventricular assist system (LVAS)–supported patients. This figure outlines a practical approach to the management of each CIED in patients with durable LVAS with the goal of minimizing adverse effects (e.g., inappropriate implantable cardioverter-defibrillator [ICD] therapies) and optimizing functional status. Nevertheless, treatment decisions must be individualized and made collaboratively between electrophysiologists and advanced heart failure specialists. ATP = antitachycardia pacing; AV = atrioventricular; CRT = cardiac resynchronization therapy; HR = heart rate; LV = left ventricular; PPM = permanent pacemaker; RV = right ventricle; SVT = supraventricular tachycardia; VF = ventricular fibrillation; VT = ventricular tachycardia. David D. Berg et al. JACC 2018;71: 2018 American College of Cardiology Foundation


Download ppt "David D. Berg et al. JACC 2018;71:"

Similar presentations


Ads by Google